Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-06-29
2009-12-08
Huynh, Phuong (Department: 1644)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S252330, C435S320100, C536S023500
Reexamination Certificate
active
07629145
ABSTRACT:
A human VEGF-related protein (VRP) has been identified and isolated that binds to, and stimulates the phosphorylation of, the receptor tyrosine kinase Flt4. The VRP is postulated to be a third member of the VEGF protein family. Also provided are antibodies that bind to VRP and neutralize a biological activity of VRP, compositions containing the VRP or antibody, methods of use, chimeric polypeptides, and a signal polypeptide for VRP.
REFERENCES:
patent: 5185438 (1993-02-01), Lemischka
patent: 5194596 (1993-03-01), Tischer et al.
patent: 5219739 (1993-06-01), Tischer et al.
patent: 5283354 (1994-02-01), Lemischka
patent: 5326695 (1994-07-01), Andersson et al.
patent: 5607918 (1997-03-01), Eriksson et al.
patent: 5776755 (1998-07-01), Alitalo et al.
patent: 5932540 (1999-08-01), Hu et al.
patent: 5935820 (1999-08-01), Hu et al.
patent: 6040157 (2000-03-01), Hu et al.
patent: 6107046 (2000-08-01), Alitalo et al.
patent: 6130071 (2000-10-01), Alitalo et al.
patent: 6221839 (2001-04-01), Alitalo et al.
patent: 6245530 (2001-06-01), Alitalo et al.
patent: 6361946 (2002-03-01), Alitalo et al.
patent: 6403088 (2002-06-01), Alitalo et al.
patent: 6451764 (2002-09-01), Lee et al.
patent: 6608182 (2003-08-01), Rosen et al.
patent: 6645933 (2003-11-01), Alitalo et al.
patent: 6730658 (2004-05-01), Alitalo et al.
patent: 6734285 (2004-05-01), Hu et al.
patent: 6818220 (2004-11-01), Alitalo et al.
patent: 6824777 (2004-11-01), Alitalo et al.
patent: 6828426 (2004-12-01), Hirata et al.
patent: 6994989 (2006-02-01), Lyman
patent: 7034105 (2006-04-01), Alitalo et al.
patent: 7109308 (2006-09-01), Rosen et al.
patent: 7115392 (2006-10-01), Rosen et al.
patent: 7125714 (2006-10-01), Alitalo et al.
patent: 7153827 (2006-12-01), Hu et al.
patent: 7153942 (2006-12-01), Hu et al.
patent: 7186688 (2007-03-01), Hu et al.
patent: 7227005 (2007-05-01), Hu et al.
patent: 7423125 (2008-09-01), Alitalo et al.
patent: 7429333 (2008-09-01), Chiou et al.
patent: 7498417 (2009-03-01), Hu et al.
patent: 2002/0120123 (2002-08-01), Rosen et al.
patent: 2002/0182683 (2002-12-01), Hu et al.
patent: 2003/0008357 (2003-01-01), Hu et al.
patent: 2003/0028007 (2003-02-01), Hu et al.
patent: 2003/0091567 (2003-05-01), Alitalo et al.
patent: 2004/0037820 (2004-02-01), Alitalo et al.
patent: 2004/0143103 (2004-07-01), Hu et al.
patent: 2004/0147448 (2004-07-01), Alitalo et al.
patent: 2004/0147726 (2004-07-01), Alitalo
patent: 2004/0208879 (2004-10-01), Alitalo et al.
patent: 2004/0213790 (2004-10-01), Lee et al.
patent: 2004/0214286 (2004-10-01), Hu et al.
patent: 2005/0176103 (2005-08-01), Hu et al.
patent: 2005/0256050 (2005-11-01), Hu et al.
patent: 2005/0287143 (2005-12-01), Rosen et al.
patent: 2006/0014252 (2006-01-01), Lyman
patent: 2006/0025331 (2006-02-01), Hu et al.
patent: 2006/0177901 (2006-08-01), Alitalo et al.
patent: 2008/0241152 (2008-10-01), Alitalo et al.
patent: 2008/0241153 (2008-10-01), Alitalo et al.
patent: 2009/0104198 (2009-04-01), Alitalo et al.
patent: 1974/8734 (1999-05-01), None
patent: 0506477 (1992-09-01), None
patent: WO 90/13649 (1990-11-01), None
patent: WO 92/14748 (1992-09-01), None
patent: WO 93/15201 (1993-08-01), None
patent: WO 94/01576 (1994-01-01), None
patent: WO 94/10202 (1994-05-01), None
patent: WO 94/11499 (1994-05-01), None
patent: WO 95/09656 (1995-04-01), None
patent: WO 95/21613 (1995-08-01), None
patent: WO 95/21865 (1995-08-01), None
patent: WO 95/21868 (1995-08-01), None
patent: WO 95/24473 (1995-09-01), None
patent: WO 95/33772 (1995-12-01), None
patent: 96/27007 (1996-09-01), None
patent: WO 96/26736 (1996-09-01), None
patent: WO 96/39421 (1996-12-01), None
patent: WO 96/39515 (1996-12-01), None
patent: WO 97/05250 (1997-02-01), None
patent: WO 97/09427 (1997-03-01), None
patent: WO 97/12972 (1997-04-01), None
patent: WO 97/17442 (1997-05-01), None
patent: WO 98/07832 (1998-02-01), None
patent: WO 98/24811 (1998-06-01), None
patent: WO 98/33917 (1998-08-01), None
patent: WO 98/49300 (1998-11-01), None
patent: WO 99/46364 (1999-09-01), None
patent: WO 00/21560 (2000-04-01), None
patent: WO 02/060950 (2002-08-01), None
Aprelikova et al., “FLT4, a Novel Class III Receptor Tyrosine Kinase in Chromosome 5q33-gter1”Cancer Research52:746-748 (1992).
Aviv et al., “Purification of Biologically Active Globin Messenger RNA by Chromatography on Oligothymidylic Acid-Cellulose”Proc. Natl. Acad. Sci. USA69(6):1408-1412 (Jun. 1972).
Bennett et al., “Cloning and Characterization of HTK, a Novel Transmembrane Tyrosine Kinase of the EPH Subfamily”Journal of Biological Chemistry269(19):14211-14218 (1994).
Bennett et al., “Extracellular Domain-IgG Fusion Proteins for Three Human Natriuretic Peptide Receptors. Hormone Pharmacology and Application to Solid Phase Screening of Synthetic Antisera”The Journal of Biological Chemistry266(34):23060-23067 (1991).
Borg et al., “Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase”Oncogene10:973-984 (1995).
Cathala et al., “Laboratory Methods. A Method for Isolation of Intact, Translationally Active Ribonucleic Acid”DNA2(4):329-335 (1983).
de Vries et al., “The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor”Science255:989-991 (1992).
Dermer, G., “Another anniversary for the war on cancer”Biotechnology12:320 (1994).
Ferrara et al., “Molecular and biological properties of the vascular endothelial growth factor family of proteins”Endo. Rev.13(1):18-32 (Feb. 1992).
Ferrara et al., “The vascular endothelial growth factor family of polypeptides”J. Cell. Biochem.47:211-218 (1991).
Ferrara, N., “Molecular and biological properties of vascular endothelial growth factor”J Mol Med77:527-543 (1999).
Finnerty et al., “Molecular Cloning of Murine FLT and FLT4”Oncogene8:2293-2298 (1993).
Folkman and Klagsbrun, “Angiogenic factors”Science235:442-447 (1987).
Folkman and Shing, “Angiogenesis”Journal of Biological Chemistry267:10931-10934 (1992).
Folkman., “Angiogenesis in Cancer, Vascular, Rheumatoid and Other Disease.”Nature Medicine.1(1):27-31 (1995).
Fong et al., “Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium”Nature376:66-70 (Jul. 6, 1995).
Galland et al., “Chromosomal Localization of FLT4, a Novel Receptor-Type Tyrosine Kinase Gene”Genomics13:475-478 (1992).
Galland et al., “The FLT4 Gene Encodes a Transmembrane Tyrosine Kinase Related to the Vascular Endothelial Growth Factor Receptor”Oncogene8:1233-1240 (1993).
GenBank Accession No. N42368, record created Jan. 25, 1996.
GenBank Accession No. N42374, record created Jan. 25, 1996.
GenBank Accession No. U43142, record created Jan. 9, 1996.
GenBank Accession No. X94216, record created Feb. 6, 1996.
GenBank Accession No. Z44272, record created Nov. 14, 1994.
Godowski et al., “Reevaluation of the Roles of Protein S and Gas6 as Ligands for the Receptor Tyrosine Kinase Rse/Tyro 3”Cell82:355-358 (Aug. 11, 1995).
Grimmond et al., “Cloning and Characterization of a Novel Human Gene Related to Vascular Endothelial Growth Factor”Genome Research6:124-131 (1996).
Gura, T., “Systems for identifying new drugs are often faulty”Science278(5340):1041-1042 (Nov. 7, 1997).
Hamel et al., “Neurotrophin gene expression by cell lines derived from human gliomas”J. Neurosci. Res.34:147-157 (1993).
Hatva et al., “Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors”Am. J. Pathol.146:368-378 (1995).
Hauser and Weich, “A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta”Growth Factors9:259-268 (1993).
Holmes et al., “Structure and Functional Expression of a Human Interleukin-8 Receptor”Science253(5025):1278-1280 (1991).
Houck et al., “The Vascul
Lee James
Wood William
Ashe, P.C.
Genentech Inc.
Huynh Phuong
LandOfFree
VEGF-related protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with VEGF-related protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and VEGF-related protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4090491